This inventor holds 126 USPTO granted patents and 35 published patent applications and 18 EPO patents, primarily in Endovascular Devices (CPC class A61F2-91). Top assignees: Trans1 Inc., Sub-Q, Incorporated, Micro Therapeutics, Inc.. Active years: 1995-2026.
Inventors with similar research interests:
Company Filing History:
35 out of 46 
16 out of 37 
11 out of 104 
Years Active: 1995-2026
Areas of Expertise:
Title: Andrew H Cragg: Pioneering Innovations in Medical Devices
Introduction:
In the fast-paced world of medical technology, inventors like Andrew H Cragg play a crucial role in advancing healthcare. With a location in Edina, MN, and an impressive number of 121 patents to his name, Cragg has made significant contributions to the field. This article explores his latest patents, career highlights, collaborations, and the lasting impact of his work.
Latest Patents:
Among Andrew H Cragg's notable inventions is the "Endovascular Occlusion Device with Hemodynamically Enhanced Sealing and Anchoring." This vascular occlusion device features an expandable frame that carries a membrane, designed to transition between open and closed configurations. This versatile device can occlude blood flow and integrate smoothly into various endovascular procedures.
Another innovative creation by Cragg is the "High Flexibility, Kink Resistant Catheter Shaft." This enhanced flexibility catheter shaft contains a distal, flexible section with a ribbed or corrugated tubular membrane. The shaft offers increased maneuverability during medical procedures and includes reinforcement structures to improve durability and performance.
Career Highlights:
During his career, Andrew H Cragg has worked with respected companies like Trans1 Inc. and Sub-Q, Incorporated. Though Trans1 Inc. and Sub-Q, Incorporated may sound unfamiliar, these companies have made significant contributions in the field of medical technology.
Collaborations:
Innovations are often the result of collaborative efforts, and Cragg has had the privilege of working alongside talented individuals. Two notable coworkers are Robert L Assell and John Logan. Their combined expertise and shared passion for medical advancements have likely fueled their achievements.
Conclusion:
Andrew H Cragg's extensive portfolio of 121 patents is a testament to his innovative spirit and dedication to improving medical technology. His vascular occlusion device and flexible catheter shaft inventions demonstrate his ability to solve critical challenges in the field. Collaborations with colleagues like Robert L Assell and John Logan have undoubtedly furthered Cragg's influence in the medical community.
As we navigate the ever-evolving landscape of healthcare, it is innovators like Andrew H Cragg who continue to push boundaries, enhance patient outcomes, and shape the future of medical technology.
Note: This article is a fictional creation based on the provided information.